Literature DB >> 2223142

Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients.

O Mathiesen1, J Carl, O Bonderup, J Panduro.   

Abstract

Axillary nodal status was analysed in 960 consecutive cases of primary invasive breast cancer operated in two Danish hospitals. After stratification according to the number of nodes removed, the rate of node positivity in each subgroup was calculated. We found that the probability of finding at least one metastatic node increased continuously up to about 10 removed nodes. In lymph node negative patients, who did not receive any adjuvant treatment, there was a significant association between the recurrence-free survival and the number of nodes removed, provided that less than 8-10 nodes had been collected. The percentage of node positivity in each subgroup seemed to level off above 10 nodes at about 64%, suggesting that this represents the true rate of node positivity at the time of primary surgery. We conclude that about 10 axillary nodes should be removed in order to minimize the risk of erroneous classification of the axilla.

Entities:  

Mesh:

Year:  1990        PMID: 2223142     DOI: 10.3109/02841869009092990

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  15 in total

1.  The reliability of sampling three to six nodes for staging breast cancer.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

2.  How to improve low lymph node recovery rates from axillary clearance specimens of breast cancer. A short-term audit.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

Review 3.  Axillary staging of breast cancer and the sentinel node.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

Review 4.  [The role of pelvic lymphadenectomy in clinically localised prostate cancer].

Authors:  M Schumacher; F C Burkhard; U E Studer
Journal:  Urologe A       Date:  2005-06       Impact factor: 0.639

5.  Estimating the overlap between sentinel lymph nodes and axillary node samples in breast cancer.

Authors:  G Cserni
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

6.  How do I deal with the axilla in patients with a positive sentinel lymph node?

Authors:  Conrad B Falkson
Journal:  Curr Treat Options Oncol       Date:  2011-12

7.  How close are we to establishing standards of lymphadenectomy for invasive bladder cancer?

Authors:  Pankaj P Dangle; Robert R Bahnson; Kamal S Pohar
Journal:  Ther Adv Urol       Date:  2009-08

8.  Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.

Authors:  R R Turner; D W Ollila; D L Krasne; A E Giuliano
Journal:  Ann Surg       Date:  1997-09       Impact factor: 12.969

9.  Lymphatic mapping and sentinel lymphadenectomy for breast cancer.

Authors:  A E Giuliano; D M Kirgan; J M Guenther; D L Morton
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

10.  Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?

Authors:  Michael Rink; Shahrokh F Shariat; Evanguelos Xylinas; John P Fitzgerald; Jens Hansen; David A Green; Ashish M Kamat; Giacomo Novara; Siamak Daneshmand; Yves Fradet; Scott T Tagawa; Patrick J Bastian; Wassim Kassouf; Quoc-Dien Trinh; Pierre I Karakiewicz; Hans-Martin Fritsche; Derya Tilki; Felix K Chun; Bjoern G Volkmer; Marko Babjuk; Axel S Merseburger; Douglas S Scherr; Yair Lotan; Robert S Svatek
Journal:  World J Urol       Date:  2012-07-26       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.